Gene Sequencing tests in Dubai & UAE

Compare available Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

143

Listed price range

2,600.00–3,200.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Gene Sequencing test prices

Showing 16–30 of 143 matching tests.

Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3496 ATP6V0A4 Gene Distal Renal Tubular Acidosis (Autosomal Recessive) NGS Test This test identifies pathogenic variants in the ATP6V0A4 gene associated with autosomal recessive distal renal tubular acidosis.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP6V0A4 gene sequence", "Pathogenic variants"] Parameters [] Preparation ["Mandatory pre-test genetic counselling", "Provide list of all prescribed drugs and supplements", "Avoid recent blood transfusion ( Indications ["Suspected autosomal recessive distal renal tubular acidosis", "Family history of dRTA", "Unexplained metabolic acidosis"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: N25.89 Clinical summary This test identifies pathogenic variants in the ATP6V0A4 gene associated with autosomal recessive distal renal tubular acidosis.
TEST-5526 CACNA1D Gene Sinoatrial Node Dysfunction and Deafness Genetic Test This genetic test identifies pathogenic variants in the CACNA1D gene associated with hereditary sinoatrial node dysfunction and sensorineural hearing loss.	Peripheral whole blood or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1D gene", "Presence of mutations causing sinoatrial node dysfunction and deafness"] Parameters [] Preparation ["No specific fasting required.", "Inform your doctor about all medications you are taking."] Indications ["Diagnosis of hereditary sinoatrial node dysfunction", "Diagnosis of hereditary bilateral sensorineural hearing loss", "Family screening for CACNA1D-related conditions"] Measurement technique Confirm with laboratory Codes LOINC: 83018-4 ICD-10: I45.5, H90.5 Clinical summary This genetic test identifies pathogenic variants in the CACNA1D gene associated with hereditary sinoatrial node dysfunction and sensorineural hearing loss.
TEST-3734 CASR Gene Hypocalcemia, Autosomal Dominant with Bartter Syndrome NGS Test This test sequences the CASR gene to detect activating mutations causing autosomal dominant hypocalcemia with Bartter syndrome.	Whole Blood, Extracted DNA, FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CASR gene sequence", "Pathogenic variants in CASR gene"] Parameters [] Preparation ["No fasting required", "Genetic counselling prior to sample collection"] Indications ["Suspected autosomal dominant hypocalcemia", "Family history of hypocalcemia", "Need for precise subclassification of calcium disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94726-9 ICD-10: E83.51 Clinical summary This test sequences the CASR gene to detect activating mutations causing autosomal dominant hypocalcemia with Bartter syndrome.
TEST-4688 CC2D2A Gene Joubert Syndrome Type 9 Genetic Test This diagnostic test evaluates the CC2D2A gene for pathogenic variants associated with Joubert syndrome type 9.	Peripheral blood (3-5 mL in EDTA) or Dried Blood Spot (FTA card)	3-4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CC2D2A gene"] Parameters [] Preparation ["No specific fasting required", "Avoid blood transfusion within 2 weeks"] Indications ["Suspected Joubert syndrome type 9", "Family history of Joubert syndrome type 9", "Genetic counseling for neurodevelopmental disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21748-6 ICD-10: Q04.3 Clinical summary This diagnostic test evaluates the CC2D2A gene for pathogenic variants associated with Joubert syndrome type 9.
TEST-4891 CD40LG Gene Immunodeficiency, X-linked with Hyper-IgM Genetic Test This test evaluates the CD40LG gene for pathogenic variants associated with X-linked hyper-IgM syndrome (HIGM1).	Peripheral Whole Blood (EDTA) or FTA Card Sample	3 – 4 weeks from sample collection	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CD40LG gene sequence", "Pathogenic variants (point mutations, deletions, insertions, deep intronic variants)"] Parameters [] Preparation [] Indications ["Clinical suspicion of X-linked hyper-IgM syndrome", "Family history consistent with X-linked inheritance", "Referral from an immunologist or genetic counselor"] Measurement technique Confirm with laboratory Codes LOINC: 96720-3 ICD-10: D82.3 Clinical summary This test evaluates the CD40LG gene for pathogenic variants associated with X-linked hyper-IgM syndrome (HIGM1).
TEST-3014 CD96 Gene C Syndrome NGS Test This test identifies pathogenic variants in the CD96 gene associated with autosomal dominant C syndrome.	Whole blood (EDTA) or dried blood spot (FTA card)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CD96 gene coding region", "Pathogenic variants (SNVs, indels)"] Parameters [] Preparation [] Indications ["Suspected C syndrome", "Craniofacial anomalies", "Developmental delay"] Measurement technique Confirm with laboratory Codes LOINC: 81261-8 ICD-10: Q87.0 Clinical summary This test identifies pathogenic variants in the CD96 gene associated with autosomal dominant C syndrome.
TEST-2106 CDC20 Gene Cell Cycle Disorder Genetic Test This genetic test evaluates the entire coding region of the CDC20 gene for variants associated with cell cycle disorders and cancer.	Peripheral whole blood, extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variations (CNVs)", "CDC20 gene sequence"] Parameters [] Preparation [] Indications ["Suspected inherited cell cycle disorder", "Cancer risk assessment", "Guidance for targeted therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Z13.79 Clinical summary This genetic test evaluates the entire coding region of the CDC20 gene for variants associated with cell cycle disorders and cancer.
TEST-2019 CEBPA Gene Somatic Mutation Analysis (NGS) for Acute Myeloid Leukemia (AML) Test This test identifies somatic mutations in the CEBPA gene using Next-Generation Sequencing (NGS) from blood, DNA, or FTA cards.	Whole blood, extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Somatic mutations in the CEBPA gene", "Variant Allele Frequency (VAF)"] Parameters [] Preparation [] Indications ["Diagnosis of Acute Myeloid Leukemia (AML)", "Risk stratification in AML", "Personalized treatment planning in AML"] Measurement technique Confirm with laboratory Codes LOINC: 69548-6 ICD-10: C92.00, C92.01, Z15.09 Clinical summary This test identifies somatic mutations in the CEBPA gene using Next-Generation Sequencing (NGS) from blood, DNA, or FTA cards.
TEST-2560 CENPE Gene Autosomal Recessive Primary Microcephaly Type 13 Genetic Test This test evaluates the CENPE gene for mutations associated with autosomal recessive primary microcephaly type 13.	Peripheral whole blood (3–5 mL in EDTA tube) or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CENPE gene sequence", "Pathogenic variants in CENPE"] Parameters [] Preparation ["No fasting required", "Keep child hydrated", "Avoid creams on venipuncture site"] Indications ["Suspected diagnosis of autosomal recessive primary microcephaly type 13", "Family history of MCPH13"] Measurement technique Confirm with laboratory Codes LOINC: 81319-2 ICD-10: Q02 Clinical summary This test evaluates the CENPE gene for mutations associated with autosomal recessive primary microcephaly type 13.
TEST-3773 CFHR3 Gene Hemolytic Uremic Syndrome Genetic Test This test evaluates the CFHR3 gene for mutations associated with atypical Hemolytic Uremic Syndrome (aHUS). It identifies pathogenic variants that disrupt complement regulation, le...	Peripheral Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CFHR3 gene sequence", "Pathogenic variants in CFHR3 gene"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session", "No specific fasting or medication restrictions mentioned"] Indications ["Suspected atypical Hemolytic Uremic Syndrome (aHUS)", "Family history of aHUS", "Need for genetic confirmation before initiating eculizumab therapy", "Family counseling and screening"] Measurement technique Confirm with laboratory Codes LOINC: 81439-3 ICD-10: D59.3 Clinical summary This test evaluates the CFHR3 gene for mutations associated with atypical Hemolytic Uremic Syndrome (aHUS). It identifies pathogenic variants that disrupt complement regulation, leading to the disease.
TEST-5512 CHMP1A Gene Pontocerebellar Hypoplasia Type 8 (PCH8) Genetic Test This test identifies pathogenic variants in the CHMP1A gene associated with Pontocerebellar Hypoplasia Type 8 (PCH8). It uses Next-Generation Sequencing (NGS) for comprehensive ana...	Whole Blood (2-3 mL), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CHMP1A gene coding regions", "CHMP1A gene splice sites", "Single nucleotide variants (SNVs)", "Insertions and deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required.", "Continue prescribed medications unless advised otherwise by your doctor."] Indications ["Suspected diagnosis of Pontocerebellar Hypoplasia Type 8 (PCH8)", "Family history of PCH8", "Genetic counselling for recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 98052-2 ICD-10: Q04.3, Z13.42, Z82.79 Clinical summary This test identifies pathogenic variants in the CHMP1A gene associated with Pontocerebellar Hypoplasia Type 8 (PCH8). It uses Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-2842 COL11A1 Gene Fibrochondrogenesis Type 1 Genetic Test This genetic test analyzes the COL11A1 gene for pathogenic variants associated with fibrochondrogenesis type 1, a severe skeletal dysplasia.	Whole Blood (Peripheral), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL11A1 gene", "Copy Number Variations (CNV) in the COL11A1 gene"] Parameters [] Preparation ["No special preparation required", "Inform phlebotomist of anticoagulant medications", "Valid Emirates ID or passport required"] Indications ["Suspected diagnosis of fibrochondrogenesis type 1", "Family history of skeletal dysplasia", "Prenatal diagnosis (following DHA guidelines and counseling)"] Measurement technique Confirm with laboratory Codes LOINC: 82161-8 ICD-10: Q77.3, Q78.8 Clinical summary This genetic test analyzes the COL11A1 gene for pathogenic variants associated with fibrochondrogenesis type 1, a severe skeletal dysplasia.
TEST-4111 COX6A1 Gene Genetic Test This test identifies pathogenic variants in the COX6A1 gene associated with mitochondrial complex IV deficiency.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COX6A1 gene", "Mitochondrial complex IV deficiency"] Parameters [] Preparation ["Genetic counseling is mandatory", "Provide detailed clinical history", "Provide three-generation pedigree chart", "Provide prior neuroimaging or metabolic reports"] Indications ["Suspected mitochondrial complex IV deficiency", "Unexplained neurological decline", "Family history of related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: E88.49 Clinical summary This test identifies pathogenic variants in the COX6A1 gene associated with mitochondrial complex IV deficiency.
TEST-5856 CSF2RB Gene Surfactant Metabolism Dysfunction Type 5 Genetic Test This genetic test evaluates the CSF2RB gene for pathogenic mutations associated with Surfactant Metabolism Dysfunction Type 5 (pulmonary alveolar proteinosis). It identifies geneti...	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CSF2RB gene sequence", "Pathogenic mutations (SNVs, indels)", "Surfactant metabolism dysfunction"] Parameters [] Preparation ["No specific fasting required.", "No medication adjustments needed unless advised by a physician."] Indications ["Infants, children, or adults presenting with unexplained pulmonary alveolar proteinosis.", "Individuals with radiological findings consistent with proteinaceous alveolar filling.", "Cases with inconclusive bronchoalveolar lavage results.", "Family history of surfactant metabolism dysfunction."] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: J84.01 Clinical summary This genetic test evaluates the CSF2RB gene for pathogenic mutations associated with Surfactant Metabolism Dysfunction Type 5 (pulmonary alveolar proteinosis). It identifies genetic variants that disrupt surfactant metabolism, leading to the accumulation of proteinaceous material in the lungs.
TEST-6074 CTSD Gene Ceroid Lipofuscinosis Neuronal Type 10 Genetic Test This genetic test identifies pathogenic variants within the CTSD gene associated with neuronal ceroid lipofuscinosis type 10 (CLN10).	Whole Blood (EDTA), FTA Card Dried Blood Spot, or Extracted DNA	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CTSD gene", "Cathepsin D enzyme function (indirectly)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomy team if on anticoagulants"] Indications ["Individuals with clinical symptoms suggestive of neuronal ceroid lipofuscinosis", "At-risk family members of a confirmed CLN10 patient", "Carrier screening for couples with a family history", "Prenatal or preimplantation genetic testing after appropriate genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 93476-7 ICD-10: E75.49 Clinical summary This genetic test identifies pathogenic variants within the CTSD gene associated with neuronal ceroid lipofuscinosis type 10 (CLN10).

Category overview

Gene Sequencing: overview

Achieving a definitive diagnosis for a complex or rare genetic disorder often requires reading the entire genetic code of specific genes to find elusive, hidden errors. As a cornerstone of our advanced Genetics services, Gene Sequencing expansively scans the targeted regions of your genome to uncover rare or novel mutations that standard tests miss. Utilizing state-of-the-art sequencing technology, this comprehensive molecular profiling delivers the critical data necessary to safely guide your healthcare provider in tailoring highly personalized medical management and targeted therapeutic interventions. Trusted for molecular excellence among premier diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and remarkably fast reporting. Find the clear, definitive answers you need—schedule your gene sequencing testing in UAE, coordinate a seamless clinical sample transfer, or consult our expert medical genetics professionals today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.